Company:  AXOGEN, INC. (AXGN)
Form Type:  8-K
Filing Date:  8/6/2013 
CIK:  0000805928 
Address:  13631 PROGRESS BLVD.
SUITE 400
 
City, State, Zip:  ALACHUA, Florida 32615 
Telephone:  (386) 462-6817 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$10.10  
Change: 
0.05 (0.50%)  
Trade Time: 
04:00 PM EST  
Market Cap: 
$333.44M
Trade AXGN now with 

© 2017  
Description of Business
We are a global leader in innovative surgical solutions for peripheral nerve injuries. We provide products and education to improve surgical treatment algorithms for peripheral nerve injuries. Our portfolio of products includes Avance® Nerve Graft, an off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site, AxoGuard® Nerve Connector, a porcine submucosa extracellular matrix ("ECM") coaptation aid for tensionless repair of severed nerves, AxoGuard® Nerve Protector, a porcine submucosa ECM product used to wrap and protect injured peripheral nerves and reinforce the nerve reconstruction while preventing soft tissue attachments and AviveTM Soft Tissue Membrane, a minimally processed human umbilical cord membrane that may be used as a resorbable soft tissue covering to separate tissues and modulate inflammation in the surgical bed.
Register and access this filing in:     
  FORM 8-K
    SECTION 5 CORPORATE GOVERNANCE
      Item 5.07 Submission of Matters to a Vote of Security Holders.
    SIGNATURE